Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Efsubaglutide Alfa

LIGHT

Shanghai Yinnuo Pharmaceutical Technology Co · Phase 2 · Completed · Enrollment 50

NCT06732960

ArmPopulationDoseWeeksEstimandWeight change
Efsubaglutide Alfa 5mgObesity or overweight5mg4n/rn/r
Efsubaglutide Alfa 7.5mgObesity or overweight7.5mg4n/rn/r
Efsubaglutide Alfa 10mgObesity or overweight10mg4n/rn/r
Efsubaglutide Alfa 15mgObesity or overweight15mg4n/rn/r
Efsubaglutide Alfa 20mgObesity or overweight20mg4n/rn/r